Menu
Back to Journals » OncoTargets and Therapy » Volume 7
Original Research
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 12,595 | Dovepress* | 9,193 | 1,550+ | 1,874 | 10,743 |
| PubMed Central* | 7 | 1,845 | 493 | 1,852 | |
| Totals | 9,200 | 3,395 | 2,367 | 12,595 | |
|
*Since 16 January 2014 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar